Key facts
- This page summarizes Thomas Pike's Form 4 filing for LABORATORY CORP OF AMERICA HOLDINGS (LH).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Jan 2023, 12:42.
Thomas Pike - 09 Jan 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)
- Reporting relationship
- Pres & CEO Clinical Business
- Issuer ticker
- LH
- Reported as of
- 09 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2023, 12:42:40 UTC
- Prior SEC filing
- 02 Dec 2022
- Next SEC filing
- 01 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra D. van der Vaart, Attorney-in-Fact for Thomas Pike
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas Pike filed Form 4 for LABORATORY CORP OF AMERICA HOLDINGS (LH) on 11 Jan 2023.
Change
- Previous filing in this sequence was filed on 02 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +16,960
- Change %
- Price
- $0.000000
- Shares after
- 16,960
- Date
- 09 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,960
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
Footnote F2
The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.